SCHEMBL6319337

SCHEMBL6319337

Cc1c(-c2ccccc2)c(N2CCN[C@@H](C)C2)c2c(nc3ccccn32)c1C#N

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK1E P49674 1/20 0.35
KHK P50053 2/20 0.34
PIK3CD O00329 3/20 0.33
ALDH1A1 P00352 2/20 0.32
KDM4E B2RXH2 2/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
ADORA2A P29274 4/20 0.32
ADRA2A P08913 2/20 0.32
HTT P42858 1/20 0.32
HSD17B10 Q99714 1/20 0.32
HPGD P15428 1/20 0.32
RXFP1 Q9HBX9 1/20 0.32
MAPK13 O15264 1/20 0.32
MAPK12 P53778 1/20 0.32
MAPK11 Q15759 1/20 0.32
MAPK14 Q16539 1/20 0.32
SLC2A1 P11166 1/20 0.32
GRM5 P41594 2/20 0.31
AURKA O14965 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6317942 0.88 KMT2A (0.38) PIK3CDALDH1A1KDM4EADORA2AADRA2A
SCHEMBL6320019 0.82 HRH4 (0.34) PIK3CDALDH1A1KDM4EADORA2AADRA2A
SCHEMBL6311792 0.79 AKT1 (0.40) ALDH1A1KDM4ESMN1; SMN2HPGD
SCHEMBL6311937 0.78 PIK3CD (0.33) KHKPIK3CDALDH1A1KDM4EHSD17B10
SCHEMBL6311653 0.78 HRH3 (0.37) PIK3CD
SCHEMBL6319498 0.77 PIK3CD (0.31) PIK3CDKDM4EADORA2AADRA2AHTT
SCHEMBL6310367 0.75 HTT (0.43) PIK3CDALDH1A1KDM4ESMN1; SMN2ADORA2A
SCHEMBL6654557 0.74 CHRM4 (0.37) ALDH1A1KDM4ENPSR1HSD17B10HPGD
SCHEMBL6310382 0.71 CKS1B (0.37)
SCHEMBL6312100 0.70 MAPK8 (0.36) KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113397-A1 Imidazo[1,2-a]pyridine derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2005-05-26 US disclosed
EP-1479681-A1 IMIDAZO(1,2-a)PYRIDINE DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2004-11-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113397-A1 Imidazo[1,2-a]pyridine derivative MANBA, MAN2B1, ERG28 CSNK1E 1010/4885KHK 1806/4885PIK3CD 2813/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.